Stay updated on rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check4 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check11 days agoChange DetectedThe webpage has been updated to include new facility names and locations, particularly in various countries, while also removing several previously listed locations. Additionally, new publications related to drug safety and interstitial lung disease have been added.SummaryDifference31%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check40 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.4%
- Check47 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.1%
Stay in the know with updates to rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.